指南与共识先天性心脏病外科

美国胸外科协会(AATS)2022专家共识文件:法洛四联症婴儿和新生儿的管理

The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: Management of infants and neonates with tetralogy of Fallot.
指南 / 共识 · J Thorac Cardiovasc Surg · 2022-10-26

该专家共识由美国胸外科协会法洛四联症临床实践标准委员会制定,采用改良德尔菲法形成推荐意见。共识指出无症状婴儿在3至6月龄行完全手术矫治合理,多数有症状新生儿可选用姑息治疗或一期完全矫治,并明确了高风险患者特征及干预选择。

要点

  • 无症状婴儿在3至6月龄行完全手术矫治可减少住院时间、不良事件率和需要跨环补片的比例。
  • 多数有症状新生儿可采用姑息治疗或一期完全手术矫治。
  • 低出生体重、早产、肺动脉细小或不连续、染色体异常等可视为高风险患者,姑息治疗可能更可取。

核心结论

  • 无症状婴儿在3至6月龄行完全手术矫治合理;多数有症状新生儿可采用姑息治疗或一期完全矫治;高风险患者可能更倾向于姑息治疗,解剖合适者导管介入可能优于外科姑息。
  • 完全矫治时经心房和经心室入路均有效,应尽可能做最小的室切口;应尽可能保留肺动脉瓣,无法保留时可考虑重建;术毕应确认右心室流出道梗阻充分解除,发现显著固定解剖梗阻应进一步干预。

研究设计与样本

  • 美国胸外科协会法洛四联症临床实践标准委员会为多国多学科专家组,经医学图书馆员协助在PubMed、Embase、Scopus和Web of Science检索2000年及以后英文文献,排除肺动脉闭锁、肺动脉瓣缺如、房室间隔缺损、成人法洛四联症及综述等非原始来源,初检近20,000条,最终纳入163篇。
  • 采用改良德尔菲法制定推荐类别和证据级别,每条声明需80%成员投票且75%同意。

主要发现

  • 无症状婴儿在3至6月龄行完全手术矫治可减少住院时间、不良事件率和需要跨环补片的比例。
  • 多数有症状新生儿中,姑息治疗和一期完全手术矫治均为有用治疗选择。
  • 低出生体重或早产、肺动脉细小或不连续、染色体异常、其他先天异常或颅内出血、脓毒症等合并症者可视为高风险患者;此类患者姑息治疗可能更可取,解剖合适者导管介入可能优于外科姑息。

关键数值与推荐

  • 无症状婴儿在3至6月龄行完全手术矫治合理(推荐类别和证据级别原文未具体列出)。
  • 多数有症状新生儿中,姑息治疗和一期完全手术矫治均为有用治疗选择(推荐类别和证据级别原文未具体列出)。
  • 低出生体重或早产、肺动脉细小或不连续、染色体异常、其他先天异常或颅内出血、脓毒症等合并症者可视为高风险患者(推荐类别和证据级别原文未具体列出)。
  • 高风险患者中姑息治疗可能更可取;解剖合适者导管介入可能优于外科姑息(推荐类别和证据级别原文未具体列出)。

临床怎么用

  • 原文未据此给出推荐。
  • 原文指出机构经验的差异可能影响该框架在临床实践中的应用。

局限性

  • 原文指出机构经验的差异可能影响该框架在临床实践中的应用。
  • 原文指出需进一步研究导管介入的作用。
  • 原文提出未来研究需回答何时姑息或行完全手术矫治及理想姑息类型、完全矫治的最佳手术入路以最佳长期保留右心室功能、各种肺动脉瓣保留和重建技术的效用、疗效和耐久性等问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite decades of experience, aspects of the management of tetralogy of Fallot with pulmonary stenosis (TOF) remain controversial. Practitioners must consider newer, evolving treatment strategies with limited data to guide decision making. Therefore, the TOF Clinical Practice Standards Committee was commissioned by the American Association for Thoracic Surgery to provide a framework on this topic, focused on timing and types of interventions, management of high-risk patients, technical considerations during interventions, and best practices for assessment of outcomes of the interventions. In addition, the group was tasked with identifying pertinent research questions for future investigations. It is recognized that variability in institutional experience could influence the application of this framework to clinical practice. METHODS: The TOF Clinical Practice Standards Committee is a multinational, multidisciplinary group of cardiologists and surgeons with expertise in TOF. With the assistance of a medical librarian, a citation search in PubMed, Embase, Scopus, and Web of Science was performed using key words related to TOF and its management; the search was restricted to the English language and the year 2000 or later. Articles pertaining to pulmonary atresia, absent pulmonary valve, atrioventricular septal defects, and adult patients with TOF were excluded, as well as nonprimary sources such as review articles. This yielded nearly 20,000 results, of which 163 were included. Greater consideration was given to more recent studies, larger studies, and those using comparison groups with randomization or propensity score matching. Expert consensus statements with class of recommendation and level of evidence were developed using a modified Delphi method, requiring 80% of the member votes with 75% agreement on each statement. RESULTS: In asymptomatic infants, complete surgical correction between age 3 and 6 months is reasonable to reduce the length of stay, rate of adverse events, and need for a transannular patch. In the majority of symptomatic neonates, both palliation and primary complete surgical correction are useful treatment options. It is reasonable to consider those with low birth weight or prematurity, small or discontinuous pulmonary arteries, chromosomal anomalies, other congenital anomalies, or other comorbidities such as intracranial hemorrhage, sepsis, or other end-organ compromise as high-risk patients. In these high-risk patients, palliation may be preferred; and, in patients with amenable anatomy, catheter-based procedures may prove favorable over surgical palliation. CONCLUSIONS: Ongoing research will provide further insight into the role of catheter-based interventions. For complete surgical correction, both transatrial and transventricular approaches are effective; however, the smallest possible ventriculotomy should be utilized. When possible, the pulmonary valve should be spared; and if unsalvageable, reconstruction can be considered. At the conclusion of the operation, adequate relief of the right ventricular outflow obstruction should be confirmed, and identification of a significant fixed anatomical obstruction should prompt further intervention. Given our current knowledge and the gaps identified, we propose several key questions to be answered by future research and potentially by a TOF registry: When to palliate or proceed with complete surgical correction, as well as the ideal type of palliation; the optimal surgical approach for complete repair for the best long-term preservation of right ventricular function; and the utility, efficacy, and durability of various pulmonary valve preservation and reconstruction techniques.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Miller JR, Stephens EH, Goldstone AB, et al. The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: Management of infants and neonates with tetralogy of Fallot. J Thorac Cardiovasc Surg. 2022. PMID: 36522807. doi:10.1016/j.jtcvs.2022.07.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。